Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction
Reynolds, John V., Ravi, Naraymasamy, Muldoon, Cian, Larkin, John O., Rowley, Suzanne, O'Byrne, Kenneth J., Hollywood, Donal, & O'Toole, Dermot (2010) Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction. World Journal of Surgery, 34(12), pp. 2821-2829.
Background Adenocarcinoma of the esophagogastric junction (AEG) as described by Siewert et al. is classified as one entity in the latest (7th Edition) American Joint Cancer Committee/International Union Against Cancer (AJCC/UICC) manual, compared with the previous mix of esophageal and gastric staging systems. The origin of AEG tumors, esophageal or gastric, and their biology remain controversial, particularly for AEG type II (cardia) tumors.
Methods We adapted a large prospective database (n = 520: 180 type I, 182 type II, 158 type III) to compare AEG tumors under the new TNM system Pathological variables associated with prognosis were compared (pT, pN, stage, differentiation, R status, lymphovascular invasion, perineural involvement, number of positive nodes, percent of positive nodes, and tumor length), as well as overall survival.
Results Compared with AEG type I tumors, type II and type III tumors had significantly (p\0.05) more advanced pN stages, greater number and percentage of positive nodes, poorer differentiation, more radial margin involvement, and more perineural invasion. In AEG type I, 14/180 patients (8%) had[6 involved nodes (pN3), compared with 16 and 30% of patients classified type II and III, respectively. Median survival was significantly (p = 0.03) improved for type I patients (38 months) compared with those with tumors classified as type II (28 months) and type III (24 months). In multivariate analysis node positivity and pN staging but not AEG site had an impact on survival.
Conclusions In this series AEG type I is associated with more favorable pathologic features and improved outcomes compared with AEG type II and III. This may reflect earlier diagnosis, but an alternative possibility, that type I may be a unique paradigm with more favorable biology, requires further study. © Société Internationale de Chirurgie 2010.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||adenocarcinoma, adult, aged, article, cancer staging, esophagus tumor, factual database, female, human, lower esophagus sphincter, male, middle aged, mortality, pathology, prognosis, prospective study, stomach tumor, survival, treatment outcome, Aged, 80 and over, Databases, Factual, Esophageal Neoplasms, Esophagogastric Junction, Humans, Neoplasm Staging, Prospective Studies, Stomach Neoplasms, Survival Analysis|
|Divisions:||Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Copyright Owner:||Copyright 2010 Springer New York LLC|
|Deposited On:||13 Dec 2013 00:31|
|Last Modified:||13 Mar 2014 02:21|
Repository Staff Only: item control page